Answer
Glibenclamide (AMGLIDIA) has a moderate influence on driving and using machines because it may increase hypoglycaemia risk; although driving may not be relevant to the target population, reduced alertness may affect cycling or play such as skateboarding.
Sources for this answer
- AMGLIDIA 0.6 mg/mL oral suspension with 1 mL oral syringeBioprojet UK Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 4Document updated
Sources checked